Related references
Note: Only part of the references are listed.New Medications Are Needed for Children With Juvenile Idiopathic Arthritis
Hermine I. Brunner et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study
Peter Nash et al.
RHEUMATOLOGY AND THERAPY (2020)
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis
Sarah Ringold et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Predicting Which Children with Juvenile Idiopathic Arthritis Will Not Attain Early Remission with Conventional Treatment: Results from the ReACCh-Out Cohort
Jaime Guzman et al.
JOURNAL OF RHEUMATOLOGY (2019)
Safety and efficacy of tofacitinib for up to 9.5years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study
Juergen Wollenhaupt et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study
Alessandro Consolaro et al.
LANCET CHILD & ADOLESCENT HEALTH (2019)
Current and future perspectives in the management of juvenile idiopathic arthritis
Nicolino Ruperto et al.
LANCET CHILD & ADOLESCENT HEALTH (2018)
Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial
Hermine I. Brunner et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study
Nicolino Ruperto et al.
PEDIATRIC RHEUMATOLOGY (2017)
Clinical outcome measures in juvenile idiopathic arthritis
Alessandro Consolaro et al.
PEDIATRIC RHEUMATOLOGY (2016)
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial
Hermine I. Brunner et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among Children Receiving Biologic Medications
Sarah Ringold et al.
ARTHRITIS AND RHEUMATISM (2013)
Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: Defining criteria based on the juvenile arthritis disease activity score
Alessandro Consolaro et al.
ARTHRITIS AND RHEUMATISM (2012)
Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
Nicolino Ruperto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
Fabrizio De Benedetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
American College of Rheumatology Provisional Criteria for Defining Clinical Inactive Disease in Select Categories of Juvenile Idiopathic Arthritis
Carol A. Wallace et al.
ARTHRITIS CARE & RESEARCH (2011)
Development and Testing of Reduced Joint Counts in Juvenile Idiopathic Arthritis
Anna Bazso et al.
JOURNAL OF RHEUMATOLOGY (2009)
Abatacept in children with juvenile idiopathic arthritis:: a randomised, double-blind, placebo-controlled withdrawal trial
Nicolino Ruperto et al.
LANCET (2008)
Adalimumab with or without methotrexate in juvenile rheumatoid arthritis
Daniel J. Lovell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis
Nicolino Ruperto et al.
ARTHRITIS AND RHEUMATISM (2007)
Etanercept in children with polyarticular juvenile rheumatoid arthritis.
DJ Lovell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
